Mevastatin was never marketed, because of its adverse effects of tumors, muscle deterioration, and sometimes death in laboratory dogs.
A mevastatina nunca foi comercializada debido aos seus efectos secundarios adversos sobre tumores, deterioración muscular, e ás veces a morte de cans de laboratorio.